Quoin Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Fund II LP(6.0%),Lind Global Partners II LLC(6.0%), etc.
Feb 13 20:16 ET
Quoin Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SEMBER MICHAEL T
Oct 30, 2023 16:14 ET
Quoin Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Dunn Gordon
Oct 30, 2023 16:12 ET
Quoin Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Myers Michael
Oct 30, 2023 16:11 ET
Quoin Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Culverwell Anthony James
Oct 30, 2023 16:10 ET
Quoin Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Cooper Joseph Patrick
Oct 30, 2023 16:08 ET
Quoin Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Leong Natalie Ee Mun
Oct 30, 2023 16:08 ET
Quoin Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Operating Officer Carter Denise P.
Oct 30, 2023 16:06 ET
Quoin Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director LANGER DENNIS
Oct 30, 2023 16:05 ET
Quoin Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director SEMBER MICHAEL T
Mar 7, 2023 19:15 ET
Quoin Pharmaceuticals | 3/A: Initial statement of beneficial ownership of securities (Amendment)-Director LANGER DENNIS
Mar 7, 2023 19:13 ET
Quoin Pharmaceuticals | 3/A: Initial statement of beneficial ownership of securities (Amendment)-Director Cooper Joseph Patrick
Mar 7, 2023 19:13 ET
Quoin Pharmaceuticals | 3/A: Initial statement of beneficial ownership of securities (Amendment)-Director Culverwell Anthony James
Mar 7, 2023 19:13 ET
Quoin Pharmaceuticals | 3/A: Initial statement of beneficial ownership of securities (Amendment)-Director Leong Natalie Ee Mun
Mar 7, 2023 19:12 ET
Quoin Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lind Global Fund II LP(9.9%),Lind Global Partners II LLC(9.9%), etc.
Mar 3, 2023 16:18 ET
Quoin Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-THE GOLDMAN SACHS GROUP, INC.(0.0 %),GOLDMAN SACHS & CO. LLC(0.0 %)
Feb 14, 2023 14:40 ET
Quoin Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CVI Investments, Inc.(4.9%),Heights Capital Management, Inc.(4.9%)
Feb 14, 2023 11:25 ET
Quoin Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Chief Executive Officer Myers Michael
Jan 3, 2023 09:47 ET
Quoin Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Cooper Joseph Patrick
Jan 3, 2023 09:45 ET
Quoin Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Chief Operating Officer Carter Denise P.
Jan 3, 2023 09:43 ET
No Data
No Data